Anthony Letai, Director of the National Cancer Institute, shared on X:
“As a physician–scientist, I’ve seen cancer’s economic toll on patients.
And a new NCI study shows costs are particularly high for end-of-life care, with averages over $121K per year.
We must do better to protect families in their hardest moments.”
Title: Cancer-attributable costs in older adults: SEER-Medicare analysis of variation by site, stage, and race
Authors: Angela B. Mariotto, Lindsey Enewold, Christopher Zeruto, Yoon Duk Hong, Douglas Lowy, K. Robin Yabroff
Read the Full Article on Journal of the National Cancer Institute
Other posts featuring Anthony Letai on OncoDaily.